Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
Abstract Background Interest in carbapenems has been rising in the last few years due to the emergence of drug resistant tuberculosis. Ertapenem (ETP), given once a day parenteral, and faropenem (FAR), oral, have a better administration profile than meropenem (MEM), imipenem (IPM) and doripenem (DOR...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2020-08-01
|
| Серія: | BMC Microbiology |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s12866-020-01954-w |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|